Magnifying endoscopy with crystal violet staining for immune checkpoint inhibitor‐associated colitis. Issue 5 (21st September 2020)
- Record Type:
- Journal Article
- Title:
- Magnifying endoscopy with crystal violet staining for immune checkpoint inhibitor‐associated colitis. Issue 5 (21st September 2020)
- Main Title:
- Magnifying endoscopy with crystal violet staining for immune checkpoint inhibitor‐associated colitis
- Authors:
- Inoue, Shuntaro
Kono, Mitsuhiro
Fukuda, Hiromu
Shimamoto, Yusaku
Nakagawa, Kentaro
Ohmori, Masayasu
Iwagami, Hiroyoshi
Matsuno, Kenshi
Iwatsubo, Taro
Nakahira, Hiroko
Matsuura, Noriko
Shichijo, Satoki
Maekawa, Akira
Kanesaka, Takashi
Yamamoto, Sachiko
Takeuchi, Yoji
Higashino, Koji
Uedo, Noriya
Kitamura, Masanori
Nakatsuka, Shinichi
Kunimasa, Kei
Kumagai, Toru
Isei, Taiki
Ishihara, Ryu - Abstract:
- Abstract: Background and Aim: There exists no evidence on the relationship between endoscopic and histologic findings. Furthermore, even after multiple biopsy specimens were obtained, histologic examination usually fails to show the characteristic features of immune checkpoint inhibitor‐associated colitis. In this study, we explored the endoscopic and histologic findings of immune checkpoint inhibitor‐associated colitis. Methods: Patients diagnosed with immune checkpoint inhibitor‐associated colitis at our hospital between March 2018 and December 2018 were retrospectively assessed. The degree of mucosal inflammation was evaluated using endoscopic inflammation grade (inactive, mild, moderate, or severe disease) and further observed using magnifying endoscopy with crystal violet staining. Pit structures were classified into three types: regularly arranged pits with circular or elliptical shape (R type), irregularly arranged pits with inhomogeneous size and morphology (IR type), and pits with reduced density or pits that partially disappeared (AD type). Results: Eleven patients (median age, 71 years; range, 44–83 years) were diagnosed with immune checkpoint inhibitor‐associated colitis. All characteristic histologic findings, including crypt distortion, crypt abscesses, and apoptotic bodies, were observed at sites with moderate‐to‐severe endoscopic inflammation but not at sites with inactive‐to‐mild endoscopic inflammation. Characteristic histologic features were observed inAbstract: Background and Aim: There exists no evidence on the relationship between endoscopic and histologic findings. Furthermore, even after multiple biopsy specimens were obtained, histologic examination usually fails to show the characteristic features of immune checkpoint inhibitor‐associated colitis. In this study, we explored the endoscopic and histologic findings of immune checkpoint inhibitor‐associated colitis. Methods: Patients diagnosed with immune checkpoint inhibitor‐associated colitis at our hospital between March 2018 and December 2018 were retrospectively assessed. The degree of mucosal inflammation was evaluated using endoscopic inflammation grade (inactive, mild, moderate, or severe disease) and further observed using magnifying endoscopy with crystal violet staining. Pit structures were classified into three types: regularly arranged pits with circular or elliptical shape (R type), irregularly arranged pits with inhomogeneous size and morphology (IR type), and pits with reduced density or pits that partially disappeared (AD type). Results: Eleven patients (median age, 71 years; range, 44–83 years) were diagnosed with immune checkpoint inhibitor‐associated colitis. All characteristic histologic findings, including crypt distortion, crypt abscesses, and apoptotic bodies, were observed at sites with moderate‐to‐severe endoscopic inflammation but not at sites with inactive‐to‐mild endoscopic inflammation. Characteristic histologic features were observed in 0%, 50%, and 100% of R‐type, IR‐type, and AD‐type mucosa, respectively. Conclusions: We revealed the possible utility of endoscopic images for selecting suitable target sites for biopsy and showed that endoscopic findings could reduce the time lag associated with tissue diagnosis and sampling errors due to biopsy. … (more)
- Is Part Of:
- Journal of gastroenterology and hepatology. Volume 36:Issue 5(2021)
- Journal:
- Journal of gastroenterology and hepatology
- Issue:
- Volume 36:Issue 5(2021)
- Issue Display:
- Volume 36, Issue 5 (2021)
- Year:
- 2021
- Volume:
- 36
- Issue:
- 5
- Issue Sort Value:
- 2021-0036-0005-0000
- Page Start:
- 1180
- Page End:
- 1186
- Publication Date:
- 2020-09-21
- Subjects:
- Colitis -- Cytotoxic T‐lymphocyte‐associated protein‐4 inhibitor -- Immune‐related adverse event -- Magnifying endoscopic findings -- Programmed death‐1 inhibitor
Gastroenterology -- Periodicals
Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
Gastroenterology -- Periodicals
Liver Diseases -- Periodicals
616.33 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1440-1746 ↗
http://onlinelibrary.wiley.com/ ↗
http://www.blackwell-synergy.com/loi/jgh ↗ - DOI:
- 10.1111/jgh.15246 ↗
- Languages:
- English
- ISSNs:
- 0815-9319
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4987.615000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 16912.xml